EUVIMEDEUVIMED entdecken
Crossref

Microfluidic organoid-slice-on-a-chip system for studying anti-cholangiocarcinoma drug efficacy and hepatorenal toxicity

Jie Liu, Guohua Wu, Di Wu, Lin Wu, Chenwei Sun, Wenlong Zhang, Qijun Du, Qinrui Lu, Wenqi Hu, Hongyu Meng iD, Zhi Luo iD, Guangzhi Liu und 3 weitere

Lab on a Chip · 2025 · 25 (12) · 2839-2850

DOI: 10.1039/d4lc00902a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lab on a Chip, 2025. Verfasst von Jie Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Biomedical Engineering, Sichuan University, Chengdu 610065, China. shuqi@scu.edu.cn. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Organoids, Lab-On-A-Chip Devices, Antineoplastic Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Organoid-slice-on-a-chip that integrated patient-derived cholangiocarcinoma organoids (CCOs) with recellularized tissue slices provides a biomimetic system for assessing anticancer drug efficacy and hepatorenal toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaOrganoidsLab-On-A-Chip DevicesAntineoplastic AgentsKidneyLiverBile Duct NeoplasmsMicrofluidic Analytical TechniquesHumans

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • College of Biomedical Engineering, Sichuan University, Chengdu 610065, China. shuqi@scu.edu.cn.
  • National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610065, China.
  • Luoyang Key Laboratory of Clinical Multiomics and Translational Medicine, Henan Key Laboratory of Rare Diseases, Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of He…
  • Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610065, China.
  • State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610065, China.
  • Beijing Institute of Nanoenergy and Nanosystems, Chinese Academy of Sciences, Beijing 101400, China.

ORCID-Profile: Hongyu Meng, Zhi Luo, Shuqi Wang

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Liu, J., Wu, G., Wu, D., Wu, L., Sun, C., Zhang, W., Du, Q., Lu, Q., Hu, W., Meng, H., Luo, Z., Liu, G., Hu, B., Hu, H., & Wang, S. (2025). Microfluidic organoid-slice-on-a-chip system for studying anti-cholangiocarcinoma drug efficacy and hepatorenal toxicity. Lab on a Chip, 25(12), 2839-2850. https://doi.org/10.1039/d4lc00902a

Vancouver

Liu J, Wu G, Wu D, Wu L, Sun C, Zhang W, et al. Microfluidic organoid-slice-on-a-chip system for studying anti-cholangiocarcinoma drug efficacy and hepatorenal toxicity. Lab on a Chip. 2025;25(12):2839-2850. doi:10.1039/d4lc00902a

BibTeX
@article{Liu2025,
  author = {Liu, Jie and Wu, Guohua and Wu, Di and Wu, Lin and Sun, Chenwei and Zhang, Wenlong and Du, Qijun and Lu, Qinrui and Hu, Wenqi and Meng, Hongyu and Luo, Zhi and Liu, Guangzhi and Hu, Bangchuan and Hu, Haijie and Wang, Shuqi},
  title = {Microfluidic organoid-slice-on-a-chip system for studying anti-cholangiocarcinoma drug efficacy and hepatorenal toxicity},
  journal = {Lab on a Chip},
  year = {2025},
  volume = {25},
  number = {12},
  pages = {2839--2850},
  doi = {10.1039/d4lc00902a}
}
Kostenlos starten →